ETFs GE HealthCare Technologies Inc.

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 01:49:16 2025-07-10 pm EDT			5-day change	1st Jan Change
76.66 ^USD	+1.52%		+0.82%	-1.91%

Jul. 09	Citigroup Raises GE Healthcare Technologies Price Target to $89 From $86, Buy Rating Maintained	MT
Jun. 30	GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell 3000 Growth Index	CI

ETFs positioned on GE HealthCare Technologies Inc.

Name	Weight	AuM	1st Jan change
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.07%	0 M€	-.--%	-
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DAILY HEDGED TO EUR - ACC - HEDGED EUR	0.07%	0 M€	-.--%	-
HSBC MSCI USA UCITS ETF - USD	0.07%	31 M€	+4.43%	-
AMUNDI INDEX MSCI WORLD - UCITS ETF DR (C) - EUR	0.05%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.05%	0 M€	-.--%	-
LYXOR NET ZERO 2050 S&P WORLD CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.05%	0 M€	-.--%	-
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (C) - EUR	0.02%	0 M€	-.--%	-
AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB UCITS ETF DR (D) - EUR	0.02%	0 M€	-.--%	-
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - DIST - EUR	0.02%	1,006 M€	-.--%	-
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - ACC - EUR	0.02%	0 M€	-8.55%	-
HAMILTON ENHANCED U.S. COVERED CALL ETF - CAD HEDGED	0.01%	488 M€	-0.58%	-
HAMILTON ENHANCED U.S. COVERED CALL ETF - USD	0.01%	51 M€	+0.14%	-

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. The Company provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.

Employees

53,000

Sector

Advanced Medical Equipment & Technology

Calendar

Jul. 29 - Q2 2025 Earnings Release

More about the company